CD8+ cell depletion amplifies the acute retroviral syndrome
The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral syndrome) is associated with alterations in the clinical profile of infection, such as a shortening of duration between infection with HIV and...
Saved in:
Published in | Journal of neurovirology Vol. 10; no. s1; pp. 58 - 66 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Informa UK Ltd
2004
|
Online Access | Get full text |
Cover
Loading…
Abstract | The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral syndrome) is associated with alterations in the clinical profile of infection, such as a shortening of duration between infection with HIV and the onset of neurocognitive impairment and acquired immunodeficiency syndrome (AIDS). Viral-specific CD8+ cytotoxic T lymphocytes (CTLs) and CD8+ natural killer (NK) cells play a key role in antiviral immunity. Loss of CD8+ cells or their functional impairment during the early period of infection is associated with a rapid progression to AIDS in nonhuman primate studies. However, no studies have determined whether CD8+ cell loss or impairment is associated with symptoms of acute retroviral illness such as fever. In this study, the authors compared the early phase of simian immunodeficiency virus (SIV) infection in animals that were treated with the anti-CD8 monoclonal antibody cM-T807 to deplete CD8+ cells during the early period of infection (SIV+ CD8− group) to those with intact CD8+ cells (SIV+ CD8+ group). The SIV+ CD8− group had an enhanced acute retroviral syndrome when compared to the SIV+ CD8+ group. The SIV+ CD8− group also had prolonged high viral loads and distinct alterations in the proinflammatory cytokines interleukin (IL)-6 and interferon (IFN)-α, as well as in monocyte chemoattractant protein (MCP)-1. CD8+ cell depletion, therefore, appears to enhance symptoms of the acute retroviral syndrome and alters several of the immunological factors associated with the early phase of infection. |
---|---|
AbstractList | The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral syndrome) is associated with alterations in the clinical profile of infection, such as a shortening of duration between infection with HIV and the onset of neurocognitive impairment and acquired immunodeficiency syndrome (AIDS). Viral-specific CD8+ cytotoxic T lymphocytes (CTLs) and CD8+ natural killer (NK) cells play a key role in antiviral immunity. Loss of CD8+ cells or their functional impairment during the early period of infection is associated with a rapid progression to AIDS in nonhuman primate studies. However, no studies have determined whether CD8+ cell loss or impairment is associated with symptoms of acute retroviral illness such as fever. In this study, the authors compared the early phase of simian immunodeficiency virus (SIV) infection in animals that were treated with the anti-CD8 monoclonal antibody cM-T807 to deplete CD8+ cells during the early period of infection (SIV+ CD8− group) to those with intact CD8+ cells (SIV+ CD8+ group). The SIV+ CD8− group had an enhanced acute retroviral syndrome when compared to the SIV+ CD8+ group. The SIV+ CD8− group also had prolonged high viral loads and distinct alterations in the proinflammatory cytokines interleukin (IL)-6 and interferon (IFN)-α, as well as in monocyte chemoattractant protein (MCP)-1. CD8+ cell depletion, therefore, appears to enhance symptoms of the acute retroviral syndrome and alters several of the immunological factors associated with the early phase of infection. |
Author | Schmitz, Jörn E Zandonatti, Michelle A Cecilia, M Reimann, Keith A Flynn, Claudia T Madden, Lisa J Fox, Howard S Taffe, Mike A Henriksen, Steven J Marcondes, G |
Author_xml | – sequence: 1 givenname: Lisa J surname: Madden fullname: Madden, Lisa J organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 2 givenname: Michelle A surname: Zandonatti fullname: Zandonatti, Michelle A organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 3 givenname: Claudia T surname: Flynn fullname: Flynn, Claudia T organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 4 givenname: Mike A surname: Taffe fullname: Taffe, Mike A organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 5 givenname: M surname: Cecilia fullname: Cecilia, M organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 6 givenname: G surname: Marcondes fullname: Marcondes, G organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 7 givenname: Jörn E surname: Schmitz fullname: Schmitz, Jörn E organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 8 givenname: Keith A surname: Reimann fullname: Reimann, Keith A organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 9 givenname: Steven J surname: Henriksen fullname: Henriksen, Steven J organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA – sequence: 10 givenname: Howard S surname: Fox fullname: Fox, Howard S organization: 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA |
BookMark | eNp1jztrwzAUhUVJoUnauav2YkeyHpHoVNwnBLq0s9HjmjjIcpCcQP59naZrp_st37nnLNAsDhEQuqekpESR1S4eJygzLYUqpbxCcyqYKirO2WxiJkRBKsVv0CLnHSGUyUrN0WP9rB6wgxCwh32AsRsiNv0-dG0HGY9bwMYdRsAJxjQcu2QCzqfo09DDLbpuTchw93eX6Pv15at-Lzafbx_106Zw0xNZOK8Ycb7lglmlgRPuNId15aYO1BGtha2Ecq4Ca63UWlmx9p4aTxS3Wkq2RKtLrktDzgnaZp-63qRTQ0lz3t5M28-caSNU82voi9HFdki92YIJ49aZBM1uOKQ4tf3X_QHFimLq |
CitedBy_id | crossref_primary_10_1186_s12865_016_0145_0 |
ContentType | Journal Article |
Copyright | 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004 |
Copyright_xml | – notice: 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004 |
DBID | AAYXX CITATION |
DOI | 10.1080/jnv.10.s1.58.66 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-2443 |
EndPage | 66 |
ExternalDocumentID | 10_1080_jnv_10_s1_58_66 |
GroupedDBID | --- -EM -~C .GJ 06D 0R~ 0VY 203 29L 29~ 2JN 2KG 2KM 2LR 2VQ 30V 34G 36B 39C 4.4 406 408 5GY 5VS 67N 8UJ 95. 96X AAAVM AABHQ AAFGU AAHNG AAIAL AAJKR AANXM AANZL AARHV AARTL AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAZMS ABDZT ABECU ABFGW ABFTV ABHLI ABIVO ABJOX ABKAS ABKCH ABMQK ABPLI ABPTK ABQBU ABSXP ABTEG ABTHY ABTMW ABULA ABXPI ACBMV ACBRV ACBYP ACGEJ ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACTTH ACVWB ACWMK ADCVX ADHHG ADHIR ADINQ ADKNI ADKPE ADMDM ADRFC ADTPH ADURQ ADXPE ADYFF ADZKW AEBTG AEFTE AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESTI AETCA AEVTX AEXYK AFKVX AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGJBK AGMZJ AGQMX AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJWEG AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS AMKLP AMYLF AMYQR ANMIH AOCGG ARMRJ AWYRJ AXYYD BGNMA CAG COF CS3 CSCUP DNIVK DU5 DX2 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FERAY FIGPU FINBP FNLPD FRP FRRFC FSGXE GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HMJXF HRMNR HZ~ IKXTQ ITM IWAJR J-C JBSCW JZLTJ KOV LLZTM M44 M4Y NPVJJ NQJWS NU0 O9- O93 O9I O9J OK1 P2P PT4 R9I RSV S1Z S27 S3A S3B SBL SHX SISQX SNE SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 T13 TFW TSG U2A U9L UG4 UOJIU UTJUX UZXMN VFIZW W2D W48 WK8 Z7U Z87 ZMTXR ZOVNA 53G AACDK AAJBT AASML AATNV AAYXX ABAKF ABJNI ABTKH ACAOD ACDTI ACZOJ AEFQL AEMSY AESKC AEVLU AFBBN AGQEE AGRTI AIGIU AMXSW CITATION DDRTE DPUIP ROL SJYHP SNPRN TDBHL |
ID | FETCH-LOGICAL-c1366-cd830cdf453b89e404c94e72c0131c0995b258cc2ebbb6998b57dd1ad084b9663 |
ISSN | 1355-0284 |
IngestDate | Thu Sep 12 18:30:46 EDT 2024 Wed Jun 21 13:15:15 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | s1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1366-cd830cdf453b89e404c94e72c0131c0995b258cc2ebbb6998b57dd1ad084b9663 |
PageCount | 9 |
ParticipantIDs | crossref_primary_10_1080_jnv_10_s1_58_66 informahealthcare_journals_10_1080_jnv_10_s1_58_66 |
PublicationCentury | 2000 |
PublicationDate | 20040000 2004-01-00 |
PublicationDateYYYYMMDD | 2004-01-01 |
PublicationDate_xml | – year: 2004 text: 20040000 |
PublicationDecade | 2000 |
PublicationTitle | Journal of neurovirology |
PublicationYear | 2004 |
Publisher | Informa UK Ltd |
Publisher_xml | – name: Informa UK Ltd |
SSID | ssj0013628 |
Score | 1.6950145 |
Snippet | The duration and severity of the symptomatology present during the early phase of human immunodeficiency virus (HIV) infection (known as the acute retroviral... |
SourceID | crossref informahealthcare |
SourceType | Aggregation Database Publisher |
StartPage | 58 |
Title | CD8+ cell depletion amplifies the acute retroviral syndrome |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbtBkovJX3RtEnQIYXC4q1lS7JMTtltQki6Oe1C6MVIsky2LdsSO4Xm12dm5VdekORihLFsrPk8Ho2--UTIDkvTnIU2CYTObcBdzIPUJSJIZVGg2olyFuudpyfycM6PTsVpb8UUq0sqM7KXd9aVPMWqcA7silWyj7Bse1M4AW2wLxzBwnB8kI0n39TnaDzE5DtSWlFHG8nFSBIvFqjdcIZiGcgEOHcV5g6wGv8ujYJeWLoSuMTit366fdr6p--LUndLST80bgaiK88JaGilwx4q_vv4ePJbXwASO0r2TBeFT4ovfjUdmuRDl3ZsiqXmxz36ETpQiF8CiFn8la5zqhBGxNe8bthDV8l6PtRLudd_Y78lyy0_74mRP5f_oDkq2UiokbyhqN1OcVABFa6ERlayTKhMyudkLQLHJAZkbe9gPD7p1p3kajfe9i0aMSgVfr3xsGtxzHqtcnvWcvZ6QcpsnbyqzUj3PFRek2du-Ya8mNb8ibdkFxAzpIgX2uKFtnihgBe6wgvt8EIbvLwj84P92eQwqLfPCCy8hwxsruLQ5gUXsVGp4yG3KXdJZFFiycLMQJhIKGsjZ4yRMO02IslzpvNQcQOz4Pg9GSz_LN0HQjnjrLBasJwnSEhWkmkbG1OkUujY2A3ypRmM7K9XScnuGfoNEt0arKz-psr7On18SqdP5KWnWWG-bJMMqvMLtwURZGW2a7NfAWuic3k |
link.rule.ids | 315,783,787,4031,27935,27936,27937 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD8%2B+cell+depletion+amplifies+the+acute+retroviral+syndrome&rft.jtitle=Journal+of+neurovirology&rft.au=Madden%2C+Lisa+J&rft.au=Zandonatti%2C+Michelle+A&rft.au=Flynn%2C+Claudia+T&rft.au=Taffe%2C+Mike+A&rft.date=2004&rft.pub=Informa+UK+Ltd&rft.issn=1355-0284&rft.eissn=1538-2443&rft.volume=10&rft.issue=s1&rft.spage=58&rft.epage=66&rft_id=info:doi/10.1080%2Fjnv.10.s1.58.66&rft.externalDocID=10_1080_jnv_10_s1_58_66 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-0284&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-0284&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-0284&client=summon |